Breethe develops the OXY-1 System, a compact cardiopulmonary support device that pumps, oxygenates, and removes carbon dioxide from blood during extracorporeal circulation. This system addresses the needs of patients with acute and chronic lung issues by providing an independent oxygen source, enabling mobility during therapy.
Funding
Funding not disclosed
Founders
Product
Problem
Patients with acute or chronic lung issues often require extracorporeal circulation, which traditionally necessitates bulky, stationary equipment. This limits patient mobility and can hinder therapy progress.
Solution
The Abiomed Breethe OXY-1 System is a compact cardiopulmonary support device designed to pump, oxygenate, and remove carbon dioxide from blood during extracorporeal circulation. The system features an integrated oxygen concentrator, providing an independent oxygen source that allows patients to move around during therapy. Its design is intended to be intuitive for healthcare providers to set up, manage, and monitor, offering advanced gas exchange technology with reduced O2 demand. The OXY-1 System is indicated for cardiopulmonary bypass up to 6 hours in duration.
Target Audience
The primary users are perfusionists, extracorporeal circulation specialists, ICU nurses with specialized extracorporeal circulation training, cardiothoracic surgeons, and intensivists requiring specialized training in extracorporeal circulation therapy.
Features
- Integrated oxygen concentrator provides an independent oxygen source.
- Compact and portable design enhances patient mobility during therapy.
- Intuitive setup and management for healthcare providers.
- Advanced gas exchange technology.
- Pumps, oxygenates, and removes carbon dioxide from blood.